Bioabsorbable Stents Market Worth 2.4 Billion USD by 2021
PUNE, India, June 16, 2016 /PRNewswire/ --
According to a new market research report "Bioabsorbable Stents Market Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) - Forecast to 2021", published by MarketsandMarkets, The global market is expected to reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% from 2016 to 2021.
(Logo: http://photos.prnewswire.com/prnh/20160303/792302 )
Browse 88 market data Tables with 43 Figures spread through 126 Pages and in-depth TOC on "Bioabsorbable Stents Market"
http://www.marketsandmarkets.com/Market-Reports/bioabsorbable-stent-market-40983380.html
Early buyers will receive 10% customization on this report.
The global Bioabsorbable Stents Market is expected to reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% during the forecast period. The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients' preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.
In this report, the Bioabsorbable Stents Market is segmented on the basis of Material, absorption rate, application, end user, and region. Based on material, the market is segmented into polymer stents, and metallic stents. The polymer stents segment is expected to grow at the highest CAGR due to the various facts such as polymer-based bioabsorbable stents comprise PLLA polymers that are naturally biodegradable. These stents have a polymer coating of poly-D, L-lactide, which enables the controlled release of various drugs.
Speak to our research experts:
http://www.marketsandmarkets.com/speaktoanalyst.asp?id=40983380
By absorption rate, the market is sub-segmented into fast and slow bioabsorbable stents. In 2016, slow absorbable stents is expected to account for the largest share of the absorption rate. The growth in this segment is attributed to slow rate of absorption enables the longer duration of drug release within the arteries. This ensures efficient healing.
Geographically, the Bioabsorbable Stents Market is dominated by Europe, followed by North America. North American market is expected to grow at the highest CAGR of 46.1% during the forecast period. This growth can be attributed to due to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.
The bioabsorbable stent market has fewer numbers of players. Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India) among others.
Related Reports:
Interventional Cardiology & Peripheral Vascular Devices Market To 2016 (Embolic Protection, Chronic Total Occlusion, Coronary Atherectomy, Thrombectomy Devices, IVUS & Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessory Devices) - Global Trends & Competitive Analysis
Bio-Implants Market - by Type (Cardiovascular, Spine, Orthopedics, Trauma, Dental), by ROA (Surgical/Injectable), by Origin (Allo/Auto/Xenograft, Synthetic) & Materials (Ceramics, Biomaterial, Alloys, Polymers) - Global Trends &, Forecasts till 2017
http://www.marketsandmarkets.com/Market-Reports/bio-implants-market-728.html
About MarketsandMarkets:
MarketsandMarkets is the world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
Mr. Rohan
Markets and Markets
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
+1-888-600-6441
Email: [email protected]
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets
SOURCE MarketsandMarkets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article